Pharmacological and ethical comparisons of lung cancer medicine accessibility in Australia and New Zealand

About this item

Title

Pharmacological and ethical comparisons of lung cancer medicine accessibility in Australia and New Zealand

Content partner

University of Otago

Collection

Otago University Research Archive

Description

Gaps in funded cancer medicines between New Zealand and Australia can have significant implications for patients and their families. Pharmac, the New Zealand pharmaceutical funding agency, has been criticised for not funding enough cancer medicines, and a 2022 review identified ethical concerns about its utilitarian focus on efficiency. However, as the costs of new cancer medicines rise along with public and political pressure to fund them, questions about value for money remain critical for ...

Read more

Format

Research paper

Research format

Scholarly text / Journal article

Date created

2024-08-28

Creator

Fenton, Elizabeth / Ashton, John

URL

https://hdl.handle.net/10523/42167

Related subjects

Cancer therapies / Chemotherapy / Cost analysis / Cost control / Decision making / Drugs / Ethics / Funding / Kinases / Lung cancer / Mortality / Native peoples / Pharmaceutical industry / Standard of care

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from University of Otago before using it.

What can I do with this item?

You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.